0000899243-21-024528.txt : 20210617 0000899243-21-024528.hdr.sgml : 20210617 20210617195437 ACCESSION NUMBER: 0000899243-21-024528 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210615 FILED AS OF DATE: 20210617 DATE AS OF CHANGE: 20210617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wanstall Rick CENTRAL INDEX KEY: 0001771222 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38130 FILM NUMBER: 211026630 MAIL ADDRESS: STREET 1: C/O AILERON THERAPEUTICS, INC. STREET 2: 490 ARSENAL WAY CITY: WATERTOWN STATE: MA ZIP: 02472 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AILERON THERAPEUTICS INC CENTRAL INDEX KEY: 0001420565 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 285 SUMMER STREET STREET 2: UNIT 101 CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 617-995-0900 MAIL ADDRESS: STREET 1: 285 SUMMER STREET STREET 2: UNIT 101 CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-15 0 0001420565 AILERON THERAPEUTICS INC ALRN 0001771222 Wanstall Rick C/O AILERON THERAPEUTICS, INC. 285 SUMMER STREET, SUITE 101 BOSTON MA 02210 0 1 0 0 See Remarks Stock Option (right to buy) 1.29 2021-06-15 4 A 0 600000 0.00 A 2031-06-14 Common Stock 600000 600000 D This option was granted on June 15, 2021. The shares underlying the option are scheduled to vest as to 25% of the shares on June 15, 2022 and thereafter in equal monthly installments through June 15, 2025. Chief Financial Officer and Treasurer /s/ Richard Wanstall 2021-06-17